Clinical trial
Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)
NCT00140530 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00140530 |
|---|---|
| Title | Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1) |
| Official title | A Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Prevention of Restenosis (ISAR-TEST-1) |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Collaborators | Bayerische Forschungsstiftung Muenchen |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Device |
| Interventions | Paclitaxel-eluting stent (Taxus), Rapamycin-eluting stent |
| Enrollment | 450 |
| Start date | Mar 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Jan 11, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: